# SX ELLA Esophageal Degradable BD Stent System

> **NCT01337206** · NA · COMPLETED · sponsor: **Cook Group Incorporated** · enrollment: 66 (actual)

## Conditions studied

- Benign Esophageal Lesions

## Interventions

- **DEVICE:** Stenting with ELLA Biodegradable stent
- **PROCEDURE:** Standard Dilations

## Key facts

- **NCT ID:** NCT01337206
- **Lead sponsor:** Cook Group Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-07
- **Final completion:** 2015-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2015-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337206, "SX ELLA Esophageal Degradable BD Stent System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01337206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*